Suppliers / Jpn Pharma

Jpn Pharma

India Updated 9 July 2026

Jpn Pharma is an API manufacturer based in India. It appears in 2 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Customs aggregates show $3.6M of exports covering 157 molecules to 42 destinations in 2025.

0
active US DMFs
0
valid CEPs
0
registered plants
2
filings across 1 regulators

What they file, and where

Molecule Regulators Docs
Silver Sulfadiazine SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 2 None

Scale

Year Revenue Exports Destinations
2025 Not reported $3.6M 42
2024 Not reported $5.4M 41
2023 Not reported $5.5M 37
2022 Not reported $5.3M 34

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Jpn Pharma

Does Jpn Pharma hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Jpn Pharma. It does have 2 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
What does Jpn Pharma make?
1 molecule is on record against Jpn Pharma, including Silver Sulfadiazine. Each links through to that molecule's full manufacturer list.
Where does Jpn Pharma file?
Filings are on record with MINSA (CR), 2 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Jpn Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts